Icon

PREVACID (nda020406)- (15MG,30MG)

LANSOPRAZOLE TAKEDA PHARMS USA
15MG,30MG
Yes No
2010-Aug-12 Expired
None None
None No
PREVACID is a proton pump inhibitor (PPI). It is indicated for: Duodenal Ulcers, H. pylori Eradication to Reduce Recurrence of Duodenal Ulcer, Benign Gastric Ulcer Short-Term Treatment, NSAID-associated Gastric Ulcer, GERD, and in Pediatric for Short-Term Treatment of Symptomatic GERD and Short-Term Treatment of EE.
15 0 10
Total Other Developers None
Drugs with Suitability No
15MG ** ** - - 7
30MG ** ** - - 8
NDA Sales Available Total Generic Sales Available
Yes 8
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ** ****** **** *** **. *****'* ************ ******* *********** ****** **. **, ** ****, ** **** & ** ****, ********** ******* *** ******, *******-********** ********,, *******-**********, ********* ******, ***** (***) ***
****** ***** ****** *** ***** ****** ******* *********** ****** ********, ******, **********, ********* *** ***, ***** (***) ***
****** ***** ******** ***** ************ ******* *********** ****** **. ***, *** *** ***, ******* ***** *. *. **. ** *******-*******, ******-****** *********, *********, ******* ******, ***** (***) ***
****** ****** **** *** *** ****** **** ******* *********** **** ***, **** **. **-***, ****-**, ***, **********, *********, ********* ******, ***** (***) ***
****** ******* ************ ******* *** *********** ******** ********** ********** *, ******** ** *******, *****, ***** (***) ***
****** ******* ************ ******* *** *********** ******* ** ********** *, ****** ** *******, ******** ** ******* *****, ***** (***) ***
****** ******** ******** ********** ******* *********** **-**/*-***/*, ********** ********* **** ********* (****), *****, *********** ******, ***** (***) ***
****** ***** **** *** ***** ************ ******* *********** **** **. ***/*, ***, ***/*, ***/* & ***/* ******* ****** ***** *****, *******, *****, ***** & *** ******, ***** (***) ***
****** ***** ******** ****** *************** ******* *********** ****, ****** ****, ******, *********, ******* ******, ***** (***) ***
****** ******** ****** *** ******** *************** ******* *********** ******* *****, **** ****** **********,****** *****, ******** *****, ******** ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.